<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sanne Terryn</style></author><author><style face="normal" font="default" size="100%">A. Francart</style></author><author><style face="normal" font="default" size="100%">S. Lamoral</style></author><author><style face="normal" font="default" size="100%">A. Hultberg</style></author><author><style face="normal" font="default" size="100%">Vanlandschoot,P.</style></author><author><style face="normal" font="default" size="100%">H Rommelaere</style></author><author><style face="normal" font="default" size="100%">A. Wittelsberger</style></author><author><style face="normal" font="default" size="100%">Michael Kalai</style></author><author><style face="normal" font="default" size="100%">Steven Van Gucht</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Treatment with anti-rabies VHH prevents or delays disease and mortality in mice depending on the timing of treatment</style></title><secondary-title><style face="normal" font="default" size="100%">First meeting of the Belgian Society for Virology</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgian</style></keyword><keyword><style  face="normal" font="default" size="100%">disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunoglobulin</style></keyword><keyword><style  face="normal" font="default" size="100%">Imogam</style></keyword><keyword><style  face="normal" font="default" size="100%">meeting</style></keyword><keyword><style  face="normal" font="default" size="100%">mice</style></keyword><keyword><style  face="normal" font="default" size="100%">mortality</style></keyword><keyword><style  face="normal" font="default" size="100%">nanobody</style></keyword><keyword><style  face="normal" font="default" size="100%">ON</style></keyword><keyword><style  face="normal" font="default" size="100%">prevent</style></keyword><keyword><style  face="normal" font="default" size="100%">prophylaxis</style></keyword><keyword><style  face="normal" font="default" size="100%">Rabies</style></keyword><keyword><style  face="normal" font="default" size="100%">Societies</style></keyword><keyword><style  face="normal" font="default" size="100%">Society</style></keyword><keyword><style  face="normal" font="default" size="100%">treatment</style></keyword><keyword><style  face="normal" font="default" size="100%">VHH</style></keyword><keyword><style  face="normal" font="default" size="100%">virology</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">8/11/2013</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">NA</style></publisher><pub-location><style face="normal" font="default" size="100%">NA</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">Belgian Society for Virology</style></issue><custom1><style face="normal" font="default" size="100%">38384</style></custom1><custom2><style face="normal" font="default" size="100%">08/11/2013</style></custom2></record></records></xml>